Promising new breakthrough against Alzheimer’s could get the go ahead
A panel of the FDA has approved a new drug from Eli Lilly that could slow the cognitive decline due to Alzheimer's.This could set the stage for the treatment to be approved for people with mild dementia caused by the disease.
The panel agreed that... Read More.
